肿瘤及瘤周肺实质CT影像组学特征预测非小细胞肺癌术后复发风险
回顾性纳入2008至2013年124例手术治疗的IA-IIB期非小细胞肺癌患者,基于肿瘤、瘤周2cm肺实质及累及肺叶的CT影像组学特征构建模型预测局部复发、远处转移及总复发。将影像组学特征与TNM分期联合后,总复发、远处转移和局部复发的AUC分别从0.680、0.672、0.580提高至0.760、0.759、0.750。高危组复发风险为低危组的16倍(p<0.001)。
要点
- 肿瘤联合瘤周2cm肺实质的CT影像组学特征可辅助预测NSCLC术后复发。
- 影像组学特征联合TNM分期较单独TNM分期的复发预测AUC提高。
- 高危组75%发生总复发,复发风险为低危组16倍(p<0.001)。
核心结论
- 肿瘤及瘤周影像组学特征联合TNM分期在手术治疗的NSCLC患者个体化复发风险评估中优于单独TNM分期。
研究设计与样本
- 回顾性收集2008至2013年124例手术治疗的IA-IIB期NSCLC患者数据,在CT图像上勾画肿瘤、瘤周2cm肺实质及累及肺叶的容积感兴趣区,提取94个影像组学特征(形态学、一阶、纹理、分形),基于单一或联合ROI建立数据集,结合影像组学特征与临床病理数据构建预测模型并以AUC评价。
诊断标准与关键数值
- TNM分期的复发预测AUC为总复发0.680、远处转移0.672、局部复发0.580;加入影像组学特征后AUC分别为总复发0.760、远处转移0.759、局部复发0.750;高危组75%发生总复发,高危组复发风险为低危组的16倍(p<0.001)。
临床应用与阅片要点
- 作者结论认为肿瘤及瘤周影像组学特征联合TNM分期可用于手术治疗的NSCLC患者个体化复发风险评估。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To estimate recurrence risk after surgery in nonsmall cell lung cancer (NSCLC) patients by employing tumoral and peritumoral radiomics analysis.
MATERIALS AND METHODS: One-hundred twenty-four surgically treated stage IA-IIB NSCLC patients' data from 2008 to 2013 were retrospectively collected. Patient outcome was defined as local recurrence (LR), distant metastasis (DM), and (sum of LR and DM) total recurrence (TR) at follow-up. Volumetric region of interests (ROIs) were drawn for the tumor, peritumoral lung parenchyma (2 cm around the tumor) and involved lobe on CT images. Ninety-four (morphological, first-order, textural, fractal-based) radiomics features were extracted from the ROIs and datasets were created from single or combined ROIs. Predictive models were built with radiomics signature (RS) and clinicopathological data, and the area under the curve (AUC) was used to evaluate the performance. Radiomics score was calculated with the best models' feature coefficients, low- and high-risk groups of patients defined accordingly. Kaplan-Meier curves were built, and the log-rank test was used for comparison among low- and high-risk groups. Differences in recurrence risk among the two risk groups were calculated (chi-square test).
RESULTS: Fifty-six patients developed TR (25 LR, 31 DM). The tumor-node-metastasis (TNM) stage recurrence predictability (AUCTR 0.680; AUCDM 0.672; AUCLR 0.580) was substantially improved when RS was added to the predictive model (AUCTR 0.760; AUCDM 0.759; AUCLR 0.750). Seventy-five percent of high-risk patients developed TR. Recurrence risk of the high-risk group was 16-fold higher than that of the low-risk group (p < 0.001).
CONCLUSION: Combination of the tumoral and peritumoral RS with TNM staging system outperformed TNM staging alone in individualized recurrence risk estimation of patients with surgically treated NSCLC.
引用
- Akinci D'Antonoli T, Farchione A, Lenkowicz J, et al. CT Radiomics Signature of Tumor and Peritumoral Lung Parenchyma to Predict Nonsmall Cell Lung Cancer Postsurgical Recurrence Risk. Acad Radiol. 2019. PMID: 31285150. doi:10.1016/j.acra.2019.05.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。